(Q57418245)

https://api.crossref.org/works/10.1016%2FS1525-8610%2804%2970407-7

7 January 2021

The prevalence of vascular dementia in Europe: facts and fragments from 1980-1990 studies. EURODEM-Prevalence Research Group.

1 reference

https://api.crossref.org/works/10.1016%2FS1525-8610%2804%2970407-7

7 January 2021

Observations on the brains of demented old people

1 reference

https://api.crossref.org/works/10.1016%2FS1525-8610%2804%2970407-7

7 January 2021

Multi-infarct dementia. A cause of mental deterioration in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS1525-8610%2804%2970407-7

7 January 2021

Multi-infarct dementia.

1 reference

https://api.crossref.org/works/10.1016%2FS1525-8610%2804%2970407-7

7 January 2021

Cerebral blood flow in dementia

1 reference

https://api.crossref.org/works/10.1016%2FS1525-8610%2804%2970407-7

7 January 2021

Binswanger's disease is not a single entity

1 reference

https://api.crossref.org/works/10.1016%2FS1525-8610%2804%2970407-7

7 January 2021

White matter hyperintensities in dementia of Alzheimer's type and in healthy subjects without cerebrovascular risk factors. A magnetic resonance imaging study.

1 reference

https://api.crossref.org/works/10.1016%2FS1525-8610%2804%2970407-7

7 January 2021

Diagnostic value of high signal abnormalities on T2 weighted MRI in the differentiation of Alzheimer's, frontotemporal and vascular dementias.

1 reference

https://api.crossref.org/works/10.1016%2FS1525-8610%2804%2970407-7

7 January 2021

Silent brain infarcts and the risk of dementia and cognitive decline

1 reference

https://api.crossref.org/works/10.1016%2FS1525-8610%2804%2970407-7

7 January 2021

Single stroke dementia: insights from 12 cases in Singapore

1 reference

https://api.crossref.org/works/10.1016%2FS1525-8610%2804%2970407-7

7 January 2021

Confusion and memory loss from capsular genu infarction: a thalamocortical disconnection syndrome?

1 reference

https://api.crossref.org/works/10.1016%2FS1525-8610%2804%2970407-7

7 January 2021

The pathology of ischemic-vascular dementia: an update

1 reference

https://api.crossref.org/works/10.1016%2FS1525-8610%2804%2970407-7

7 January 2021

Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer's Disease Diagnostic and Treatment Centers

1 reference

https://api.crossref.org/works/10.1016%2FS1525-8610%2804%2970407-7

7 January 2021

Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop

1 reference

https://api.crossref.org/works/10.1016%2FS1525-8610%2804%2970407-7

7 January 2021

Clinical criteria for the diagnosis of vascular dementia: a multicenter study of comparability and interrater reliability.

1 reference

https://api.crossref.org/works/10.1016%2FS1525-8610%2804%2970407-7

7 January 2021

Clinical-neuropathologic findings in multi-infarct dementia: a report of six autopsied cases

1 reference

https://api.crossref.org/works/10.1016%2FS1525-8610%2804%2970407-7

7 January 2021

Clinicopathological analysis of dementia disorders in the elderly.

1 reference

https://api.crossref.org/works/10.1016%2FS1525-8610%2804%2970407-7

7 January 2021

Multicenter clinicopathological correlation in dementia

1 reference

https://api.crossref.org/works/10.1016%2FS1525-8610%2804%2970407-7

7 January 2021

Vascular Dementia Is Underdiagnosed

1 reference

https://api.crossref.org/works/10.1016%2FS1525-8610%2804%2970407-7

7 January 2021

Sensitivity and specificity of newly proposed clinical criteria for possible vascular dementia

1 reference

https://api.crossref.org/works/10.1016%2FS1525-8610%2804%2970407-7

7 January 2021

Dementia after stroke: Baseline frequency, risks, and clinical features in a hospitalized cohort

1 reference

https://api.crossref.org/works/10.1016%2FS1525-8610%2804%2970407-7

7 January 2021

Clinical factors associated with dementia in ischaemic stroke

1 reference

https://api.crossref.org/works/10.1016%2FS1525-8610%2804%2970407-7

7 January 2021

Magnetic resonance imaging in vascular dementia

1 reference

https://api.crossref.org/works/10.1016%2FS1525-8610%2804%2970407-7

7 January 2021

Dementia in stroke survivors in the Stroke Data Bank cohort. Prevalence, incidence, risk factors, and computed tomographic findings

1 reference

https://api.crossref.org/works/10.1016%2FS1525-8610%2804%2970407-7

7 January 2021

Preexisting dementia in stroke patients. Baseline frequency, associated factors, and outcome

1 reference

https://api.crossref.org/works/10.1016%2FS1525-8610%2804%2970407-7

7 January 2021

Influence of prestroke dementia on early and delayed mortality in stroke patients

1 reference

https://api.crossref.org/works/10.1016%2FS1525-8610%2804%2970407-7

7 January 2021

Dementia associated with lacunar infarction

1 reference

https://api.crossref.org/works/10.1016%2FS1525-8610%2804%2970407-7

7 January 2021

Risk of dementia after stroke in a hospitalized cohort: results of a longitudinal study.

1 reference

https://api.crossref.org/works/10.1016%2FS1525-8610%2804%2970407-7

7 January 2021

Vascular risk factors for Alzheimer's disease: an epidemiologic perspective.

1 reference

https://api.crossref.org/works/10.1016%2FS1525-8610%2804%2970407-7

7 January 2021

A cholesterol-lowering drug reduces beta-amyloid pathology in a transgenic mouse model of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1525-8610%2804%2970407-7

7 January 2021

Hypercholesterolemia accelerates the Alzheimer's amyloid pathology in a transgenic mouse model

1 reference

https://api.crossref.org/works/10.1016%2FS1525-8610%2804%2970407-7

7 January 2021

Coronary artery disease, hypertension, ApoE, and cholesterol: a link to Alzheimer's disease?

1 reference

https://api.crossref.org/works/10.1016%2FS1525-8610%2804%2970407-7

7 January 2021

Cholesterol and Alzheimer's disease: is there a link?

1 reference

https://api.crossref.org/works/10.1016%2FS1525-8610%2804%2970407-7

7 January 2021

Midlife blood pressure and neuritic plaques, neurofibrillary tangles, and brain weight at death: the HAAS. Honolulu-Asia aging Study

1 reference

https://api.crossref.org/works/10.1016%2FS1525-8610%2804%2970407-7

7 January 2021

Increased incidence of neurofibrillary tangles (NFT) in non-demented individuals with hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS1525-8610%2804%2970407-7

7 January 2021

Cardiovascular disease and distribution of cognitive function in elderly people: the Rotterdam Study

1 reference

https://api.crossref.org/works/10.1016%2FS1525-8610%2804%2970407-7

7 January 2021

Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study

1 reference

https://api.crossref.org/works/10.1016%2FS1525-8610%2804%2970407-7

7 January 2021

Diabetes mellitus and the risk of dementia: The Rotterdam Study.

1 reference

https://api.crossref.org/works/10.1016%2FS1525-8610%2804%2970407-7

7 January 2021

The role of APOE epsilon4 in modulating effects of other risk factors for cognitive decline in elderly persons

1 reference

https://api.crossref.org/works/10.1016%2FS1525-8610%2804%2970407-7

7 January 2021

Treatment for the secondary prevention of stroke in older patients: the influence of dementia status

1 reference

https://api.crossref.org/works/10.1016%2FS1525-8610%2804%2970407-7

7 January 2021

Aspirin use and cognitive function in the elderly.

1 reference

https://api.crossref.org/works/10.1016%2FS1525-8610%2804%2970407-7

7 January 2021

Is there any evidence for a protective effect of antithrombotic medication on cognitive function in men at risk of cardiovascular disease? Some preliminary findings

1 reference

https://api.crossref.org/works/10.1016%2FS1525-8610%2804%2970407-7

7 January 2021

Randomized clinical trial of daily aspirin therapy in multi-infarct dementia. A pilot study.

1 reference

https://api.crossref.org/works/10.1016%2FS1525-8610%2804%2970407-7

7 January 2021

Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS1525-8610%2804%2970407-7

7 January 2021

Dementia and disability outcomes in large hypertension trials: lessons learned from the systolic hypertension in the elderly program (SHEP) trial

1 reference

https://api.crossref.org/works/10.1016%2FS1525-8610%2804%2970407-7

7 January 2021

Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial

1 reference

https://api.crossref.org/works/10.1016%2FS1525-8610%2804%2970407-7

7 January 2021

Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS1525-8610%2804%2970407-7

7 January 2021

A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia. North American EGb Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1525-8610%2804%2970407-7

7 January 2021

Overview of clinical trials of hydergine in dementia

1 reference

https://api.crossref.org/works/10.1016%2FS1525-8610%2804%2970407-7

7 January 2021

Clinical trials in dementia with propentofylline

1 reference

https://api.crossref.org/works/10.1016%2FS1525-8610%2804%2970407-7

7 January 2021

Propentofylline in the treatment of Alzheimer's disease and vascular dementia: a review of phase III trials

1 reference

https://api.crossref.org/works/10.1016%2FS1525-8610%2804%2970407-7

7 January 2021

The treatment of chronic cerebrovascular insufficiency. A double-blind study with pentoxifylline (‘Trental’ 400)

1 reference

https://api.crossref.org/works/10.1016%2FS1525-8610%2804%2970407-7

7 January 2021

Haemorheological pattern in initial mental deterioration: results of a long-term study using piracetam and pentoxifylline.

1 reference

https://api.crossref.org/works/10.1016%2FS1525-8610%2804%2970407-7

7 January 2021

Pentoxifylline in cerebrovascular dementia.

1 reference

https://api.crossref.org/works/10.1016%2FS1525-8610%2804%2970407-7

7 January 2021

European Pentoxifylline Multi-Infarct Dementia Study

1 reference

https://api.crossref.org/works/10.1016%2FS1525-8610%2804%2970407-7

7 January 2021

An efficacy and safety analysis of Exelon in Alzheimer's disease patients with concurrent vascular risk factors

1 reference

https://api.crossref.org/works/10.1016%2FS1525-8610%2804%2970407-7

7 January 2021

Efficacy of galantamine in probable vascular dementia and Alzheimer's disease combined with cerebrovascular disease: a randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS1525-8610%2804%2970407-7

7 January 2021

Donepezil-treated patients with probable vascular dementia demonstrate cognitive benefits

1 reference

https://api.crossref.org/works/10.1016%2FS1525-8610%2804%2970407-7

7 January 2021

A 24-week, randomized, double-blind study of donepezil in moderate to severe Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1525-8610%2804%2970407-7

7 January 2021

Efficacy of donepezil on behavioral symptoms in patients with moderate to severe Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1525-8610%2804%2970407-7

7 January 2021

Efficacy of donepezil on maintenance of activities of daily living in patients with moderate to severe Alzheimer's disease and the effect on caregiver burden

1 reference

https://api.crossref.org/works/10.1016%2FS1525-8610%2804%2970407-7

7 January 2021

A randomized, double-blind, placebo-controlled study of the efficacy and safety of donepezil in patients with Alzheimer's disease in the nursing home setting

1 reference

https://api.crossref.org/works/10.1016%2FS1525-8610%2804%2970407-7

7 January 2021